Literature DB >> 29449121

Sleep disorders and Parkinson disease; lessons from genetics.

Ziv Gan-Or1, Roy N Alcalay2, Guy A Rouleau3, Ronald B Postuma4.   

Abstract

Parkinson disease is a common, age-related neurodegenerative disorder, projected to afflict millions of individuals in the near future. Understanding its etiology and identifying clinical, genetic or biological markers for Parkinson disease onset and progression is therefore of major importance. Various sleep-related disorders are the most common group of non-motor symptoms in advanced Parkinson disease, but they can also occur during its prodromal phase. However, with the exception of REM sleep behavior disorder, it is unclear whether they are part of the early pathological process of Parkinson disease, or if they develop as Parkinson disease advances because of treatments and neurodegeneration progression. The advancements in genetic studies in the past two decades have generated a wealth of information, and recent genetic studies offer new insight on the association of sleep-related disorders with Parkinson disease. More specifically, comparing genetic data between Parkinson disease and sleep-related disorders can clarify their association, which may assist in determining whether they can serve as clinical markers for Parkinson disease risk or progression. In this review, we discuss the current knowledge on the genetics of sleep-related disorders in Parkinson disease context, and the potential implications on research, diagnosis, counseling and treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GBA; Genetics; Glucocerebrosidase; Neurodegeneration; Parkinson disease; RBD; RLS; Rapid eye movement sleep behavior disorder; Restless legs syndrome

Mesh:

Substances:

Year:  2018        PMID: 29449121     DOI: 10.1016/j.smrv.2018.01.006

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  15 in total

Review 1.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

Review 2.  Genetics of circadian rhythms and sleep in human health and disease.

Authors:  Jacqueline M Lane; Jingyi Qian; Emmanuel Mignot; Susan Redline; Frank A J L Scheer; Richa Saxena
Journal:  Nat Rev Genet       Date:  2022-08-26       Impact factor: 59.581

3.  Sleep Quality and Related Clinical Manifestations in Huntington Disease.

Authors:  Sabrina Maffi; Eugenia Scaricamazza; Simone Migliore; Melissa Casella; Consuelo Ceccarelli; Ferdinando Squitieri
Journal:  J Pers Med       Date:  2022-05-25

4.  [Changes of brain structural network properties in patients with rapid eye movement sleep behavior disorder].

Authors:  Ruirui Zhang; Zhonglin Li; Yingying Bai; Pengfei Xu; Jiewen Zhang; Hongju Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

5.  Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications.

Authors:  Xiaohui Tang; Lijia Yu; Jingyun Yang; Wenjing Guo; Ying Liu; Yaling Xu; Xijin Wang
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

6.  Sleep Disorders in Parkinson's Disease: Present Status and Future Prospects.

Authors:  Yun Shen; Chun-Feng Liu
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

7.  Sleep fragmentation as an important clinical characteristic of sleep disorders in Parkinson's disease: a preliminary study.

Authors:  Guo-En Cai; Shan Luo; Li-Na Chen; Jian-Ping Lu; Yu-Jie Huang; Qin-Yong Ye
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

8.  Leg restlessness preceding the onset of motor symptoms of Parkinson disease: A case series of 5 patients.

Authors:  Keisuke Suzuki; Hiroaki Fujita; Yuji Watanabe; Takeo Matsubara; Taro Kadowaki; Hirotaka Sakuramoto; Mai Hamaguchi; Narihiro Nozawa; Koichi Hirata
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.

Authors:  Md Mahbubur Rahman; Rupali Rani Chakraborti; Md Abdullah Potol; Ariful Haque Abir; Ozayra Sharmin; Mahabub Alam; Md Fazlur Rahman Khan; Rownock Afrin; Humayra Jannat; Rasiqh Wadud; Zaki Farhad Habib
Journal:  Animal Model Exp Med       Date:  2019-12-30

10.  Abnormal Global Brain Functional Connectivity in Primary Insomnia Patients: A Resting-State Functional MRI Study.

Authors:  Chao-Qun Yan; Xu Wang; Jian-Wei Huo; Ping Zhou; Jin-Ling Li; Zhong-Yan Wang; Jie Zhang; Qing-Nan Fu; Xue-Rui Wang; Cun-Zhi Liu; Qing-Quan Liu
Journal:  Front Neurol       Date:  2018-11-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.